Acetohydroxamic Acid
AHA-PLUS-MDRTB-2026
Phase 2 small_molecule active
Quick answer
Acetohydroxamic Acid for Multidrug-Resistant Tuberculosis is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Multidrug-Resistant Tuberculosis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active